scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1084972388 |
P356 | DOI | 10.1038/NPP.2017.80 |
P932 | PMC publication ID | 5561347 |
P698 | PubMed publication ID | 28425496 |
P50 | author | Adelaide R Minerva | Q87871269 |
P2093 | author name string | Kenner C Rice | |
Leonard L Howell | |||
Agnieszka Sulima | |||
Jordan N Kohn | |||
Elizabeth G Pitts | |||
Meghan T Logun | |||
Erika B Chandler | |||
P2860 | cites work | The safety and efficacy of {+/-}3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study | Q24606265 |
Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study | Q24620135 | ||
Adult birdsong is actively maintained by error correction. | Q24657611 | ||
Medial prefrontal cortex 5-HT(2A) density is correlated with amygdala reactivity, response habituation, and functional coupling | Q25001700 | ||
Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans | Q26859367 | ||
Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder | Q27015917 | ||
Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis) | Q27329826 | ||
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin | Q28143430 | ||
No evidence that MDMA-induced enhancement of emotional empathy is related to peripheral oxytocin levels or 5-HT1a receptor activation | Q28540131 | ||
A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3,4 methylenedioxymethamphetamine ("ecstasy") | Q28577690 | ||
WAY-163909 [(7bR, 10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a novel 5-hydroxytryptamine 2C receptor-selective agonist with anorectic activity | Q28582332 | ||
Effects of acute MDMA intoxication on mood and impulsivity: role of the 5-HT2 and 5-HT1 receptors | Q28727300 | ||
Observational study of behavior: sampling methods | Q29547830 | ||
Effects of pharmacologic dopamine β-hydroxylase inhibition on cocaine-induced reinstatement and dopamine neurochemistry in squirrel monkeys | Q33750819 | ||
Stereospecific analysis and enantiomeric disposition of 3, 4-methylenedioxymethamphetamine (Ecstasy) in humans | Q33866538 | ||
Endocrine and neurochemical effects of 3,4-methylenedioxymethamphetamine and its stereoisomers in rhesus monkeys | Q34035262 | ||
The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals. | Q34495787 | ||
Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques | Q34552306 | ||
3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors | Q34558760 | ||
Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration. | Q34989613 | ||
Role of dopamine transporters in the behavioral effects of 3,4-methylenedioxymethamphetamine (MDMA) in nonhuman primates | Q35590703 | ||
Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylene | Q37161392 | ||
Sertraline effects on cerebrospinal fluid monoamines and species-typical socioemotional behavior of female cynomolgus monkeys | Q37638436 | ||
Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions. | Q38048826 | ||
Functional anatomy of 5-HT2A receptors in the amygdala and hippocampal complex: relevance to memory functions | Q38099540 | ||
Vocalization as an emotional indicator. A neuroethological study in the squirrel monkey | Q39681642 | ||
The varieties of ecstatic experience: an exploration of the subjective experiences of ecstasy | Q40359394 | ||
Ambient temperature effects on 3,4-methylenedioxymethamphetamine-induced thermodysregulation and pharmacokinetics in male monkeys | Q40444221 | ||
Role of the serotonin 5-HT2A receptor in the hyperlocomotive and hyperthermic effects of (+)-3,4-methylenedioxymethamphetamine | Q40513141 | ||
Blockade of striatal 5-hydroxytryptamine2 receptors reduces the increase in extracellular concentrations of dopamine produced by the amphetamine analogue 3,4-methylenedioxymethamphetamine | Q42491091 | ||
The behavioral repertoire of the squirrel monkey (Saimiri). | Q43318153 | ||
Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram | Q43842041 | ||
Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT(2) antagonist ketanserin in healthy humans | Q43842050 | ||
Microglial and astroglial activation by 3,4-methylenedioxymethamphetamine (MDMA) in mice depends on S(+) enantiomer and is associated with an increase in body temperature and motility | Q44599215 | ||
Differential effects of intravenous R,S-(+/-)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its S(+)- and R(-)-enantiomers on dopamine transmission and extracellular signal regulated kinase phosphorylation (pERK) in the rat nucleus accumbens | Q48138239 | ||
Serotonin 5-HT1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study | Q48340449 | ||
Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice. | Q48437323 | ||
MDMA-induced c-Fos expression in oxytocin-containing neurons is blocked by pretreatment with the 5-HT-1A receptor antagonist WAY 100635. | Q49064161 | ||
Disruption of primate social behavior by d-amphetamine and cocaine: Differential antagonism by antipsychotics | Q51864369 | ||
The 5-HT1A antagonist, WAY 100 635, alleviates cognitive impairments induced by dizocilpine (MK-801) in monkeys. | Q52169847 | ||
Analysis of amphetamine effects on agonistic and affiliative behavior in squirrel monkeys (Saimiri sciureus). | Q52505322 | ||
Three points to consider when choosing a LM or GLM test for count data | Q57239134 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1962-1971 | |
P577 | publication date | 2017-04-20 | |
P1433 | published in | Neuropsychopharmacology | Q2261280 |
P1476 | title | 3,4-Methylenedioxymethamphetamine Increases Affiliative Behaviors in Squirrel Monkeys in a Serotonin 2A Receptor-Dependent Manner | |
P478 | volume | 42 |
Q47777762 | (±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA. |
Q89231003 | Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) and R(-) MDMA on actigraphy-based daytime activity and sleep parameters in rhesus monkeys |
Q57176236 | Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine |
Q47662199 | Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice |
Q38600048 | Serotonin and brain function: a tale of two receptors |
Search more.